Viridian Therapeutics, Inc./DE Preferred Stock, Shares Issued
Viridian Therapeutics, Inc./DE (VRDN) had Preferred Stock, Shares Issued of 0 shares as of 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2021-08-12
- 2021-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2021-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2020-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2020-09-30: Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 0.00 shares 10-Q · filed 2021-08-12 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-12 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-26 |
| 2016-12-31 | 0.00 shares 10-K · filed 2017-03-24 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-10-26 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-16 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-24 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-13 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-14 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-21 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |